GLP-1 medications are a breakthrough for weight loss and metabolic healthbut commonly cause digestive side effects that can hinder adherence
We feel that it is important to have experienced staff, in partnership with the patient, make decisions about dosing
In many cases, injections are administered into the fatty tissue of the abdomen, thigh, or upper arm, as directed
Check-ins continue monthly
States Offering Broad GLP-1 Coverage for Obesity A total of 14 states, including California, Michigan, and Pennsylvania, provide Medicaid coverage for the most common GLP-1s approved for either Type 2 diabetes or obesity
Glickman agrees, adding, Trulicity and Ozempic are both effective tools for managing type 2 diabetes, but semaglutide (Ozempic/Wegovy) stands out for its superior efficacy in both glycemic control and weight loss